Ursodeoxycholic Acid Market Trends, Growth, Demand, opportunities, Scope & Forecast 2023 by CMI
Ursodeoxycholic acid, commonly known as ursodiol, is a kind of deoxycholic acid (USAN). Ursodeoxycholic acid (3a, 7ß-2-hydroxy-5ß-bile acid, UDCA) was discovered in a black bear's bile for the first time. Ursodeoxycholic acid is an essential clinical medication used to treat gallstones, cholecystitis, PBC, and PSC with a large market. Ursodeoxycholic acid was previously synthesized using a standard organic synthesis method.
Ursodeoxycholic acid is a liver
disease treatment. Ursodeoxycholic acid has a beneficial effect on liver
disease treatment. Synthetic Ursodeoxycholic Acid and Extraction
Ursodeoxycholic Acid is two types of Ursodeoxycholic Acid. In 2017, Synthetic
Ursodeoxycholic Acid made up about 73.4 percent of the total, whereas
Extraction Ursodeoxycholic Acid made up around 26.57 percent.
The Ursodeoxycholic Acid Market is
expected to grow at a 10.4 percent CAGR in revenue over the following five
years, reaching US$ 960 million by 2023, up from US$ 530 million in 2017. The global ursodeoxycholic acid market
size was valued at US$ 457.3 million in 2017 and is expected to exhibit a CAGR
of 10.1% over the forecast period (2018 – 2026).
Ursodeoxycholic Acid is used in
pharmaceuticals and health care products. Ursodeoxycholic Acid is most commonly
used in health products, with a market share of approximately 69.2% in
2017.With a consumption market share of over 47 percent in 2017, Asia-Pacific
is the largest consumer region. With a consumption market share of 26.6 percent
in 2017, Europe is the second-largest consumption region after Asia-Pacific.
The majority of China's output is
destined for export. Asia is the primary consumer market. The two largest
consumer countries are Japan and South Korea. Ursodeoxycholic acid is mostly
employed in the Asian healthcare business for traditional reasons.
In 2017, Europe was the leading
supplier of Ursodeoxycholic Acid, with a production revenue market share of
over 41% and a sales market share of 26.4 percent. That is to say, Europe has a
diverse range of exports. Asia is also the leading supplier of Ursodeoxycholic
Acid, with a market share of approximately 42 percent in production income and
47 percent in sales in 2017.
Dipharma Francis Srl, ERREGIERRE
S.p.A., Grindeks, Industria Chimica Emiliana, Mitsubishi Tanabe Pharma
Corporation, Zhongshan Belling Biotechnology Co., Glenmark Pharmaceutical
Limited, Arbil Chempharma Private Limited, Biotavia Labs Pvt Ltd, Daewoong Bio
Inc., PharmaZell GmbH, and Suzhou Tianlu Bio-pharmaceutical Co., Ltd. are among
the major players in the global

Comments
Post a Comment